|
|
Introduction |
Green Cross applying itself closely to the special medicines for more than 30 years took over SangA Pharmaceuticals to extend its pipeline to OTC in 2001. At present, Green Cross continues to manufacture the major existing products such as cataplasms, roborants and digestive, entering into a strategic alliance with bioventure corporation to extend its product portpolio to the product related to the atopic dermatitis, and the enhancement of immunity. Green Cross is planning to enhance the OTC sector to meet the trend of emphasizing the quality of life as much as the treatment of disease.
|
|
|
